Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes

被引:0
|
作者
Pei-Fen Chen [1 ,2 ]
Xia-Xia Yu [3 ]
Yi-Peng Liu [1 ]
Di Ren [4 ]
Min Shen [5 ]
Bing-Sheng Huang [6 ]
Jun-Ling Gao [7 ]
Zheng-Yang Huang [3 ]
Ming Wu [8 ]
Wei-Yan Wang [5 ]
Li Chen [5 ]
Xia Shi [5 ]
Zhao-Qing Wang [5 ]
Ying-Xia Liu [5 ]
Lei Liu [5 ]
Yong Liu [9 ]
机构
[1] Department of Respiratory Diseases, Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Diseases, Shenzhen Third People's Hospital, The Second Hospital Affiliated to
[2] Department of Infectious Diseases, Linzhi People's Hospital
[3] School of Biomedical Engineering, Health Science Center, Shenzhen University
[4] Expert Panel of Shenzhen 2019-nCoV Pneumonia, The Second People's Hospital of Shenzhen
[5] Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Diseases, Shenzhen Third People's Hospital, The Second Hospital Affiliated to Southern University of Science and
[6] Medical AI Laboratory, School of Biomedical Engineering, Health Science Centre, Shenzhen University
[7] Buddhism and Science Research Laboratory, Centre of Buddhist Studies, The University of Hong Kong
[8] ICU, The Second People's Hospital of Shenzhen
[9] Expert Panel of Shenzhen 2019-nCoV Pneumonia, Shenzhen Hospital, Southern Medical University
关键词
D O I
暂无
中图分类号
R563.1 [肺炎];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Understanding a virus shedding patterns in body fluids/secretions is important to determine the samples to be used for diagnosis and to formulate infection control measures.AIM To investigate the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) shedding patterns and its risk factors.METHODS All laboratory-confirmed coronavirus disease 2019 patients with complete medical records admitted to the Shenzhen Third People’s Hospital from January 28, 2020 to March 8, 2020 were included. Among 145 patients(54.5% males; median age, 46.1 years), three(2.1%) died. The bronco-alveolar lavage fluid(BALF) had the highest virus load compared with the other samples. The viral load peaked at admission(3.3 × 108 copies) and sharply decreased 10 d after admission.RESULTS The viral load was associated with prolonged intensive care unit(ICU) duration. Patients in the ICU had significantly longer shedding time compared to those in the wards(P < 0.0001). Age > 60 years [hazard ratio(HR) = 0.6; 95% confidence interval(CI): 0.4-0.9] was an independent risk factor for SARS-CoV-2 shedding, while chloroquine(HR = 22.8; 95%CI: 2.3-224.6) was a protective factor.CONCLUSION BALF had the highest SARS-CoV-2 load. Elderly patients had higher virus loads, which was associated with a prolonged ICU stay. Chloroquine was associated with shorter shedding duration and increased the chance of viral negativity.
引用
收藏
页码:6252 / 6263
页数:12
相关论文
共 50 条
  • [31] Novel Corona Virus (SARS-CoV-2)
    Honemann, Mario
    Lubbert, Christoph
    Liebert, Uwe G.
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (03): : 213 - 214
  • [32] Novel Corona Virus (SARS-CoV-2)
    Hoenemann, Mario
    Luebbert, Christoph
    Liebert, Uwe G.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (05) : 336 - 337
  • [33] Immunopathology of SARS-CoV-2 virus infection
    Javier Espinosa-Rosales, Francisco
    [J]. ACTA PEDIATRICA DE MEXICO, 2020, 41 (04): : S42 - S50
  • [34] Coinfection with SARS-CoV-2 and influenza A virus
    Kondo, Yuki
    Miyazaki, Shinichi
    Yamashita, Ryo
    Ikeda, Takuya
    [J]. BMJ CASE REPORTS, 2020, 13 (07)
  • [35] VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern
    O'Donnell, Kyle L.
    Gourdine, Tylisha
    Fletcher, Paige
    Shifflett, Kyle
    Furuyama, Wakako
    Clancy, Chad S.
    Marzi, Andrea
    [J]. VACCINES, 2022, 10 (03)
  • [36] Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees
    Takahashi, Kenichiro
    Ishikane, Masahiro
    Ujiie, Mugen
    Iwamoto, Noriko
    Okumura, Nobumasa
    Sato, Testsuro
    Nagashima, Maki
    Moriya, Ataru
    Suzuki, Michiyo
    Hojo, Masayuki
    Kanno, Takayuki
    Saito, Shinji
    Miyamoto, Sho
    Ainai, Akira
    Tobiume, Minoru
    Arashiro, Takeshi
    Fujimoto, Tsuguto
    Saito, Tomoya
    Yamato, Masaya
    Suzuki, Tadaki
    Ohmagari, Norio
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (05) : 998 - 1001
  • [37] Duration of SARS-CoV-2 Culturable Virus Shedding in Children by Vaccination Status-Reply
    Kumar, Nikhilesh
    Bendavid, Eran
    Sood, Neeraj
    [J]. JAMA PEDIATRICS, 2024, 178 (04) : 421 - 421
  • [38] Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
    Boucau, Julie
    Marino, Caitlin
    Regan, James
    Uddin, Rockib
    Choudhary, Manish C.
    Flynn, James P.
    Chen, Geoffrey
    Stuckwisch, Ashley M.
    Mathews, Josh
    Liew, May Y.
    Singh, Arshdeep
    Lipiner, Taryn
    Kittilson, Autumn
    Melberg, Meghan
    Li, Yijia
    Gilbert, Rebecca F.
    Reynolds, Zahra
    Iyer, Surabhi L.
    Chamberlin, Grace C.
    Vyas, Tammy D.
    Goldberg, Marcia B.
    Vyas, Jatin M.
    Li, Jonathan Z.
    Lemieux, Jacob E.
    Siedner, Mark J.
    Barczak, Amy K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03): : 275 - 277
  • [39] Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets
    Belser, Jessica A.
    Sun, Xiangjie
    Kieran, Troy J.
    Brock, Nicole
    Pulit-Penaloza, Joanna A.
    Pappas, Claudia
    Basu Thakur, Poulami
    Jones, Joyce
    Wentworth, David E.
    Zhou, Bin
    Tumpey, Terrence M.
    Maines, Taronna R.
    [J]. JOURNAL OF VIROLOGY, 2022, 96 (24)
  • [40] Investigation of SARS-CoV-2 IgG Binding Capability to Variants of the SARS-CoV-2 Virus
    Johnson, Lucy
    De Gascun, Cillian F.
    Hassan, Jaythoon
    [J]. VIRAL IMMUNOLOGY, 2024,